Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kitae Kim

Showing results (251-260 of 314) with videos related to

Pageof 32
Sort By:
Thrombosis Research|February 9, 2024
The impact of renal function on clinical outcomes of patients with cancer-associated isolated distal deep vein thrombosis: Insights from the ONCO DVT studyDaisuke Sueta, Yugo Yamashita, Takeshi Morimoto, et al.
Research and Practice in Thrombosis and Haemostasis|April 14, 2025
Clinical outcomes of cancer-associated isolated distal deep vein thrombosis: a comparison between asymptomatic and symptomatic thrombosis-findings from the ONCO DVT StudyYoshito Ogihara, Yugo Yamashita, Takeshi Morimoto, et al.
Journal of Thrombosis and Thrombolysis|April 28, 2026
Number of thrombosed venous segments and clinical outcomes in cancer-associated isolated distal deep vein thrombosis: insights from the ONCO DVT StudyKanna Nakamura, Yugo Yamashita, Takeshi Morimoto, et al.
Thrombosis Research|August 14, 2025
Impact of thrombocytopenia in patients with cancer-associated isolated distal deep vein thrombosis treated with edoxaban for 12 months versus 3 months: Insights from the ONCO DVT studyYutaro Miyoshi, Yugo Yamashita, Takeshi Morimoto, et al.
JACC. Asia|December 20, 2025
Predictors of Bleeding Complications After Extracorporeal Cardiopulmonary Resuscitation: Insights From the SAVE-J II StudyMadoka Sano, Toshiaki Toyota, Yoshinori Matsuoka, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|September 18, 2024
Impact of Anemia on Clinical Outcomes of Patients With Cancer-Associated Isolated Distal Deep Vein Thrombosis Receiving Edoxaban　- Insights From the ONCO DVT StudyShinya Fujiki, Yugo Yamashita, Takeshi Morimoto, et al.
Journal of Thrombosis and Haemostasis : JTH|September 16, 2024
Utility of the modified Ottawa score for identification of more preferable candidates of extended anticoagulation therapy in cancer-associated isolated distal deep vein thrombosis: insight from the ONCO DVT StudyWei Xiong, Yugo Yamashita, Takeshi Morimoto, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 22, 2024
Edoxaban for 12 vs. 3 months in cancer-associated isolated distal deep vein thrombosis according to different doses: insights from the ONCO DVT studyRyuki Chatani, Yugo Yamashita, Takeshi Morimoto, et al.
International Journal of Cardiology|September 9, 2021
Severity of pulmonary embolism at initial diagnosis and long-term clinical outcomes: From the COMMAND VTE RegistryYugo Yamashita, Takeshi Morimoto, Kazushige Kadota, et al.
Blood Vessels, Thrombosis & Hemostasis|August 6, 2025
D-dimer after 3 months of anticoagulation therapy and outcomes in cancer-associated isolated distal deep vein thrombosisTatsuya Nishikawa, Yugo Yamashita, Masashi Fujita, et al.
Pageof 32

Showing results (251-260 of 314) with videos related to

Sort By:
Pageof 32
Thrombosis Research|February 9, 2024
The impact of renal function on clinical outcomes of patients with cancer-associated isolated distal deep vein thrombosis: Insights from the ONCO DVT studyDaisuke Sueta, Yugo Yamashita, Takeshi Morimoto, et al.
Research and Practice in Thrombosis and Haemostasis|April 14, 2025
Clinical outcomes of cancer-associated isolated distal deep vein thrombosis: a comparison between asymptomatic and symptomatic thrombosis-findings from the ONCO DVT StudyYoshito Ogihara, Yugo Yamashita, Takeshi Morimoto, et al.
Journal of Thrombosis and Thrombolysis|April 28, 2026
Number of thrombosed venous segments and clinical outcomes in cancer-associated isolated distal deep vein thrombosis: insights from the ONCO DVT StudyKanna Nakamura, Yugo Yamashita, Takeshi Morimoto, et al.
Thrombosis Research|August 14, 2025
Impact of thrombocytopenia in patients with cancer-associated isolated distal deep vein thrombosis treated with edoxaban for 12 months versus 3 months: Insights from the ONCO DVT studyYutaro Miyoshi, Yugo Yamashita, Takeshi Morimoto, et al.
JACC. Asia|December 20, 2025
Predictors of Bleeding Complications After Extracorporeal Cardiopulmonary Resuscitation: Insights From the SAVE-J II StudyMadoka Sano, Toshiaki Toyota, Yoshinori Matsuoka, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|September 18, 2024
Impact of Anemia on Clinical Outcomes of Patients With Cancer-Associated Isolated Distal Deep Vein Thrombosis Receiving Edoxaban　- Insights From the ONCO DVT StudyShinya Fujiki, Yugo Yamashita, Takeshi Morimoto, et al.
Journal of Thrombosis and Haemostasis : JTH|September 16, 2024
Utility of the modified Ottawa score for identification of more preferable candidates of extended anticoagulation therapy in cancer-associated isolated distal deep vein thrombosis: insight from the ONCO DVT StudyWei Xiong, Yugo Yamashita, Takeshi Morimoto, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 22, 2024
Edoxaban for 12 vs. 3 months in cancer-associated isolated distal deep vein thrombosis according to different doses: insights from the ONCO DVT studyRyuki Chatani, Yugo Yamashita, Takeshi Morimoto, et al.
International Journal of Cardiology|September 9, 2021
Severity of pulmonary embolism at initial diagnosis and long-term clinical outcomes: From the COMMAND VTE RegistryYugo Yamashita, Takeshi Morimoto, Kazushige Kadota, et al.
Blood Vessels, Thrombosis & Hemostasis|August 6, 2025
D-dimer after 3 months of anticoagulation therapy and outcomes in cancer-associated isolated distal deep vein thrombosisTatsuya Nishikawa, Yugo Yamashita, Masashi Fujita, et al.
Pageof 32